HCW Biologics (HCWB) Competitors $0.43 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCWB vs. CYAD, TTOO, LMNL, ENLV, SGTX, CTXR, ENTX, SPRO, EPIX, and OMGAShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include Celyad Oncology (CYAD), T2 Biosystems (TTOO), Liminal BioSciences (LMNL), Enlivex Therapeutics (ENLV), Sigilon Therapeutics (SGTX), Citius Pharmaceuticals (CTXR), Entera Bio (ENTX), Spero Therapeutics (SPRO), ESSA Pharma (EPIX), and Omega Therapeutics (OMGA). These companies are all part of the "medical" sector. HCW Biologics vs. Celyad Oncology T2 Biosystems Liminal BioSciences Enlivex Therapeutics Sigilon Therapeutics Citius Pharmaceuticals Entera Bio Spero Therapeutics ESSA Pharma Omega Therapeutics HCW Biologics (NASDAQ:HCWB) and Celyad Oncology (NASDAQ:CYAD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, community ranking, media sentiment, profitability, valuation and dividends. Does the MarketBeat Community favor HCWB or CYAD? Celyad Oncology received 279 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 67.70% of users gave Celyad Oncology an outperform vote. CompanyUnderperformOutperformHCW BiologicsOutperform Votes6100.00% Underperform VotesNo VotesCelyad OncologyOutperform Votes28567.70% Underperform Votes13632.30% Do institutionals and insiders believe in HCWB or CYAD? 3.0% of HCW Biologics shares are held by institutional investors. 49.9% of HCW Biologics shares are held by company insiders. Comparatively, 0.9% of Celyad Oncology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is HCWB or CYAD more profitable? Celyad Oncology has a net margin of 0.00% compared to HCW Biologics' net margin of -978.03%. Celyad Oncology's return on equity of 0.00% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets HCW Biologics-978.03% -385.90% -126.44% Celyad Oncology N/A N/A N/A Do analysts prefer HCWB or CYAD? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ACelyad Oncology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media favor HCWB or CYAD? In the previous week, HCW Biologics' average media sentiment score of 0.00 equaled Celyad Oncology'saverage media sentiment score. Company Overall Sentiment HCW Biologics Neutral Celyad Oncology Neutral Which has stronger valuation & earnings, HCWB or CYAD? Celyad Oncology has lower revenue, but higher earnings than HCW Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHCW Biologics$2.84M5.73-$24.99M-$1.04-0.41Celyad Oncology$110K144.65-$9.14MN/AN/A SummaryCelyad Oncology beats HCW Biologics on 6 of the 10 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.26M$7.03B$5.40B$8.53BDividend YieldN/A7.96%5.13%4.14%P/E Ratio-0.419.93115.5615.18Price / Sales5.73381.421,484.3492.77Price / CashN/A47.3439.6634.07Price / Book1.165.324.665.02Net Income-$24.99M$153.56M$119.06M$225.46M7 Day Performance-7.03%0.11%0.80%0.37%1 Month Performance-10.79%15.22%5.65%3.57%1 Year Performance-72.33%41.14%36.76%29.44% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics1.1279 of 5 stars$0.43flatN/A-73.0%$16.26M$2.84M-0.4140Short Interest ↓Gap UpCYADCelyad OncologyN/A$0.60flatN/A+0.0%$15.91M$110,000.000.0095High Trading VolumeTTOOT2 Biosystems1.8145 of 5 stars$0.85-3.4%$5.00+487.6%-85.7%$14.87M$7.19M0.00180LMNLLiminal BioSciencesN/A$8.50+0.1%N/A+0.0%$26.35M$310,000.0029.31251ENLVEnlivex Therapeutics3.3974 of 5 stars$1.36+0.7%$6.00+341.2%+2.4%$29.11MN/A-1.1570News CoverageSGTXSigilon TherapeuticsN/A$22.47-2.6%N/A+0.0%$56.40M$12.94M-1.8462CTXRCitius Pharmaceuticals2.3124 of 5 stars$0.36-2.7%$4.00+1,014.5%-53.4%$64.86MN/A-1.5020Positive NewsENTXEntera Bio2.8986 of 5 stars$1.80-0.6%$10.00+455.6%+170.4%$64.41M$57,000.00-6.9220Short Interest ↓Positive NewsGap UpSPROSpero Therapeutics4.5912 of 5 stars$1.18-4.1%$7.00+493.2%+3.5%$63.71M$103.78M3.5846News CoverageHigh Trading VolumeEPIXESSA Pharma2.2823 of 5 stars$1.40-73.1%$16.50+1,078.6%-71.2%$62.12MN/A-2.2650News CoverageGap DownHigh Trading VolumeOMGAOmega Therapeutics1.4332 of 5 stars$1.11-4.3%$10.20+818.9%-17.8%$61.22M$3.09M-0.78120 Related Companies and Tools Related Companies Celyad Oncology Competitors T2 Biosystems Competitors Liminal BioSciences Competitors Enlivex Therapeutics Competitors Sigilon Therapeutics Competitors Citius Pharmaceuticals Competitors Entera Bio Competitors Spero Therapeutics Competitors ESSA Pharma Competitors Omega Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HCWB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
